S&P 500   4,662.85
DOW   35,911.81
QQQ   380.01
S&P 500   4,662.85
DOW   35,911.81
QQQ   380.01
S&P 500   4,662.85
DOW   35,911.81
QQQ   380.01
S&P 500   4,662.85
DOW   35,911.81
QQQ   380.01

Eden Research Share Forecast, Price & News

GBX 7.50
+0.25 (+3.45%)
(As of 01/14/2022 02:34 PM ET)
Today's Range
50-Day Range
52-Week Range
68,720 shs
Average Volume
121,353 shs
Market Capitalization
£28.53 million
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive EDEN News and Ratings via Email

Sign-up to receive the latest news and ratings for Eden Research and its competitors with MarketBeat's FREE daily newsletter.

Eden Research logo

About Eden Research

Eden Research plc offers sustainable solutions for crop protection, animal health, and consumer products in the United Kingdom and rest of Europe. The company provides various plant protection products, such as foliar disease and insect control, open field and greenhouses, soil pests, protected glass house crops, shelf-life extension, seed treatment, and post-harvest applications. It also offers treatment for various pathogens that effect animal health, as well as provides animal health products, such as shampoos, conditioners, companion animal products, bio-control products, parasite treatments, flea and tick control, skin disease control products, OTIC flush treatment, and insect sprays. In addition, the company offers human health products comprising head-lice, fragrances, wound-care, deodorants, odour neutralisers, food flavorings, and biocide active ingredients products. The company was incorporated in 1995 and is headquartered in Oxfordshire, the United Kingdom.


As NFT sales top $4 billion, what's in store for 2022?
January 12, 2022 |  finance.yahoo.com
See More Headlines

Industry, Sector and Symbol

Agricultural Chemicals
Year Founded

Sales & Book Value

Annual Sales
£1.56 million
Cash Flow
GBX 1.52 per share
Book Value
GBX 3.60 per share


Pretax Margin




Free Float
Market Cap
£28.53 million
Not Optionable

Company Calendar

Last Earnings


Overall MarketRank

0.85 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Eden Research (LON:EDEN) Frequently Asked Questions

How has Eden Research's stock price been impacted by Coronavirus (COVID-19)?

Eden Research's stock was trading at GBX 6.15 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, EDEN stock has increased by 22.0% and is now trading at GBX 7.50.
View which stocks have been most impacted by COVID-19

How were Eden Research's earnings last quarter?

Eden Research plc (LON:EDEN) released its quarterly earnings data on Tuesday, September, 29th. The company reported ($0.40) earnings per share for the quarter.
View Eden Research's earnings history

Who are Eden Research's key executives?

Eden Research's management team includes the following people:
  • Mr. Sean M. Smith, CEO & Director
  • Mr. Alexander John Abrey, CFO & Director
  • Dr. Aoife Dillon, Global Head of Biology & Devel.

What other stocks do shareholders of Eden Research own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Eden Research investors own include Kromek Group (KMK), Primary Health Properties (PHP), Cabot Energy (CAB), National Grid (NG), Ophir Energy (OPHR), Gigamon (GIMO), Marston's (MARS), Mothercare (MTC), Synopsys (SNPS) and AFC Energy (AFC).

What is Eden Research's stock symbol?

Eden Research trades on the London Stock Exchange (LON) under the ticker symbol "EDEN."

How do I buy shares of Eden Research?

Shares of EDEN and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Eden Research's stock price today?

One share of EDEN stock can currently be purchased for approximately GBX 7.50.

How much money does Eden Research make?

Eden Research has a market capitalization of £28.53 million and generates £1.56 million in revenue each year.

How many employees does Eden Research have?

Eden Research employs 7 workers across the globe.

What is Eden Research's official website?

The official website for Eden Research is www.edenresearch.com.

Where are Eden Research's headquarters?

How can I contact Eden Research?

Eden Research's mailing address is Priory Crt Business Park, 6 Priory Court, CIRENCESTER, GL7 5JB, United Kingdom. The company can be reached via phone at +44-1285-359555.

This page was last updated on 1/17/2022 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.